Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00215384 · ClinicalTrials.gov registry record · Phase 2
Study in Patients With COPD
A Phase 2 study, sponsored by Dey.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00215384 is a Phase 2 study that has completed, run by Dey. The registered enrollment target is 35 participants.
The verdict
NCT00215384, a Phase 2 study, has completed, sponsored by Dey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective compared to the control drug.
Interventions
- DRUG Formoterol Fumarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Est. Completion | 2005-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00215384
The ClinicalTrials.gov registry entry for NCT00215384 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dey, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Formoterol Fumarate is the first listed.
NCT00215384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00215384 about?
NCT00215384 is a clinical study titled "Study in Patients With COPD". The purpose of this study is to determine which dose of the investigational drug is the most safe and effective compared to the control drug.
What is the current status of trial NCT00215384?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00215384?
The interventions under investigation include: Formoterol Fumarate (DRUG).
Who is sponsoring clinical trial NCT00215384?
This trial is sponsored by Dey, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.